Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Genital Herpes - Pipeline Review, H1 2018, provides an overview of the Genital Herpes (Infectious Disease) pipeline landscape.
Genital herpes is a common sexually transmitted infection that affects both men and women. Genital herpes is caused by the herpes simplex virus (HSV). Symptoms include decreased appetite, fever, general sick feeling (malaise), muscle aches in the lower back, buttocks, thighs, or knees and swollen and tender lymph nodes in the groin during an outbreak. Treatment includes antiviral medications.
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Genital Herpes - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Genital Herpes (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Genital Herpes (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Genital Herpes and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 5, 3, 16 and 2 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.
Genital Herpes (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Genital Herpes (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Genital Herpes (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Genital Herpes (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Genital Herpes (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Genital Herpes (Infectious Disease)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Genital Herpes (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Genital Herpes (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Genital Herpes - Pipeline Review, H1 2018
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Genital Herpes - Overview
Genital Herpes - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Genital Herpes - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Genital Herpes - Companies Involved in Therapeutics Development
Abivax SA
Admedus Ltd
AiCuris GmbH & Co KG
Biomere LLC
GenVec Inc
Immune Design Corp
NanoBio Corp
NanoViricides Inc
Profectus BioSciences Inc
Redbiotec AG
Sanofi Pasteur SA
Starpharma Holdings Ltd
Vaccibody AS
Vical Inc
Genital Herpes - Drug Profiles
ABX-196 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Aspidasept - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
astodrimer - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
G-103 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
genital herpes (virus like particle) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
genital herpes vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
genital herpes vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
genital herpes vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
genital herpes vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GV-2207 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
herpes simplex virus [type 1, 2] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
herpes simplex virus 2 vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
herpes simplex virus 2 vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
herpes simplex virus 2 vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
herpes simplex virus 2 vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HSV-529 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NN-001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pritelivir - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Profavax HSV-1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Profavax HSV-2 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule for Genital Herpes - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Theravax HSV-1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Theravax HSV-2 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
triptorelin acetate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
VCLHB-01 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
VCLHM-01 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
VMTX-004 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Genital Herpes - Dormant Projects
Genital Herpes - Discontinued Products
Genital Herpes - Product Development Milestones
Featured News & Press Releases
Jan 30, 2018: Vical Provides Update on its Genital Herpes Drug Candidate VCL-HB01
May 04, 2017: Admedus Releases Results of HSV-2 Phase IIa Study
May 02, 2017: Vical Provides Update On Therapeutic Vaccine HSV-2 During its Research and Development Day
Apr 19, 2017: Vical Completes Target Enrollment in Its Phase 2 Therapeutic HSV-2 Vaccine Trial
Mar 06, 2017: NanoBio Receives SBIR Grant For Genital Herpes Vaccine
Dec 01, 2016: AiCuris Announces Start of LipP 1: First Subject Enrolled in the Clinical Phase 2 Trial with Topical Pritelivir for the Treatment of recurrent Labial Herpes
Oct 19, 2016: Admedus Announces Positive Unblinded HSV-2 Phase II Interim Data
Jun 20, 2016: Vicals Phase 1/2 Trial Data Presented at ASM 2016 Shows Bivalent Vaccine Imparts Reduction in Genital Herpes Lesions Durable to 9 Months
Mar 04, 2016: Interim HSV-2 Phase II clinical trial data encouraging
Feb 03, 2016: Model helps decide drug dose for clinical testing
Sep 22, 2015: NanoBio's Genital Herpes Vaccine Demonstrates Efficacy In Guinea Pigs As Both A Prophylactic And A Therapeutic Vaccine
Jun 22, 2015: Vical Reports Top-Line Results From Phase 1/2 Trial of Therapeutic Genital Herpes Vaccine
Apr 10, 2015: Admedus has high hopes for Herpes vaccine as dosing commences
Oct 08, 2014: NanoBio To Present Data Demonstrating The Potential For Its Intranasal Vaccine To Protect Against Genital Herpes Infection
Oct 02, 2014: Admedus Announces Further Data From Herpes Simplex Vaccine Trial
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Genital Herpes, H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..1), H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Products under Development by Companies, H1 2018
Products under Development by Companies, H1 2018 (Contd..1), H1 2018
Products under Development by Universities/Institutes, H1 2018
Number of Products by Stage and Target, H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018
Number of Products by Stage and Route of Administration, H1 2018
Number of Products by Stage and Molecule Type, H1 2018
Genital Herpes - Pipeline by Abivax SA, H1 2018
Genital Herpes - Pipeline by Admedus Ltd, H1 2018
Genital Herpes - Pipeline by AiCuris GmbH & Co KG, H1 2018
Genital Herpes - Pipeline by Biomere LLC, H1 2018
Genital Herpes - Pipeline by GenVec Inc, H1 2018
Genital Herpes - Pipeline by Immune Design Corp, H1 2018
Genital Herpes - Pipeline by NanoBio Corp, H1 2018
Genital Herpes - Pipeline by NanoViricides Inc, H1 2018
Genital Herpes - Pipeline by Profectus BioSciences Inc, H1 2018
Genital Herpes - Pipeline by Redbiotec AG, H1 2018
Genital Herpes - Pipeline by Sanofi Pasteur SA, H1 2018
Genital Herpes - Pipeline by Starpharma Holdings Ltd, H1 2018
Genital Herpes - Pipeline by Vaccibody AS, H1 2018
Genital Herpes - Pipeline by Vical Inc, H1 2018
Genital Herpes - Dormant Projects, H1 2018
Genital Herpes - Dormant Projects, H1 2018 (Contd..1), H1 2018
Genital Herpes - Discontinued Products, H1 2018
List of Figures
Number of Products under Development for Genital Herpes, H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products by Targets, H1 2018
Number of Products by Stage and Targets, H1 2018
Number of Products by Mechanism of Actions, H1 2018
Number of Products by Stage and Mechanism of Actions, H1 2018
Number of Products by Routes of Administration, H1 2018
Number of Products by Stage and Top 10 Routes of Administration, H1 2018
Number of Products by Molecule Types, H1 2018
Number of Products by Stage and Molecule Types, H1 2018
Global Sexually Transmitted Diseases Testing Professional Survey Report 2023, Forecast to 2028
Published: 22-Dec-2023 Price: US 3280 Onwards Pages: 106
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
D......
Global Sexually Transmitted Diseases Testing Market Research Report 2023, Forecast to 2028
Published: 22-Dec-2023 Price: US 2680 Onwards Pages: 130
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
D......
Global Sexually Transmitted Disease (STD) Testing Market Status and Outlook 2023-2028
Published: 23-Nov-2023 Price: US 3160 Onwards Pages: 102
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
D......
Global Sexually Transmitted Disease (Std) Testing Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 05-Oct-2023 Price: US 3380 Onwards Pages: 100
Market Overview of Global Sexually Transmitted Disease (Std) Testing market:
According to our latest research, the global Sexually Transmitted Disease (Std) Testing market looks promising in the next 5 years. As of 2022, the global Sexually Transmitted Disease (Std) Testing market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and pr......
Global Gonorrhea Therapeutics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 05-Oct-2023 Price: US 3380 Onwards Pages: 98
Market Overview of Global Gonorrhea Therapeutics market:
According to our latest research, the global Gonorrhea Therapeutics market looks promising in the next 5 years. As of 2022, the global Gonorrhea Therapeutics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Gonorrhea is a sexually transmitted disease (STD) caused by the bacterium Neisseria gonorrhea. It tends to infect the urethra......
Global Gonorrhea Therapeutics Market Insights, Forecast to 2029
Published: 14-Aug-2023 Price: US 4900 Onwards Pages: 89
Gonorrhea is a sexually transmitted disease (STD) that affects both men and women. The infection affects the genitals, rectum, and the throat. The treatment landscape typically involves the use of antibiotics with dual therapy dominating the market compared with monotherapy. As the market has a deep penetration of generics, the growth rate is expected to be moderate during the forecast period. Additionally, the advent of new antibiotic-resistant strains will continue to hinder the growth prospec......
Global Sexually Transmitted Disease (STD) Testing Market Insights, Forecast to 2029
Published: 01-Jun-2023 Price: US 4900 Onwards Pages: 92
Sexually Transmitted Disease (STD) Testing is a medical means of testing, prevention, and treatment of Sexually Transmitted Disease (STD).
Market Analysis and Insights: Global Sexually Transmitted Disease (STD) Testing Market
The global Sexually Transmitted Disease (STD) Testing market is projected to grow from US$ 225.3 million in 2023 to US$ 338.1 million by 2029, at a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period.
The need for tests that eliminate ......
Global Sexually Transmitted Disease (STD) Testing Market Research Report 2023
Published: 05-May-2023 Price: US 2900 Onwards Pages: 89
Sexually Transmitted Disease (STD) Testing is a medical means of testing, prevention, and treatment of Sexually Transmitted Disease (STD).
Highlights
The global Sexually Transmitted Disease (STD) Testing market was valued at US$ 225.3 million in 2022 and is anticipated to reach US$ 338.1 million by 2029, witnessing a CAGR of 7.0% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The need ......
Global Gonorrhea Therapeutics Market Status and Outlook 2023-2028
Published: 24-Apr-2023 Price: US 3160 Onwards Pages: 104
Neisseria gonorrhoeae infection can manifest as a variety of symptoms, which can affect the genitourinary system, anorectum, pharynx, and conjunctival area. Severe cases can lead to disseminated gonococcal infection, endocarditis and meningitis; in women, it is pelvic inflammatory disease (PID).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
